{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:44:25Z","timestamp":1792669465215,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.bbi.2012.08.005","type":"journal-article","created":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T11:47:48Z","timestamp":1344944868000},"page":"1273-1279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":178,"title":["Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: Further evidence for disease course-related immune alterations?"],"prefix":"10.1016","volume":"26","author":[{"given":"Stefan","family":"Busse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Busse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolja","family":"Schiltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Bielau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Gos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Brisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mawrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Gert","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Bogerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2012.08.005_b0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.schres.2006.11.016","article-title":"Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial","volume":"90","author":"Akhondzadeh","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2012.08.005_b0010","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1471-4159.1993.tb13620.x","article-title":"Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells","volume":"61","author":"Alonso","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2012.08.005_b0015","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/brain\/awg118","article-title":"B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas","volume":"126","author":"Anthony","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2012.08.005_b0020","unstructured":"APA, 2000. Diagnostic and Statistical Manual of Mental Disorders, 4th revised edition (DSM-IV-TR). American Psychiatric Press, Washington, DC."},{"key":"10.1016\/j.bbi.2012.08.005_b0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1192\/bjp.141.3.273","article-title":"Impairment of the blood-brain barrier as an aetiological factor in paranoid psychosis","volume":"141","author":"Axelsson","year":"1982","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2006.11.007","article-title":"What is the blood-brain barrier (not)?","volume":"28","author":"Bechmann","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbi.2012.08.005_b0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jpsychires.2009.08.008","article-title":"Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction","volume":"44","author":"Bechter","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2012.08.005_b0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0925-4927(96)03002-8","article-title":"Confirmation of reduced temporal limbic structure volume on magnetic resonance imaging in male patients with schizophrenia","volume":"67","author":"Becker","year":"1996","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2012.08.005_b0045","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2174\/187152711798072392","article-title":"Nitric oxide and schizophrenia: present knowledge and emerging concepts of therapy","volume":"10","author":"Bernstein","year":"2011","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.bbi.2012.08.005_b0050","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1586\/ern.09.59","article-title":"Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy","volume":"9","author":"Bernstein","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbi.2012.08.005_b0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/schbul\/23.3.423","article-title":"The temporolimbic system theory of positive schizophrenic symptoms","volume":"23","author":"Bogerts","year":"1997","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2012.08.005_b0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0006-3223(93)90289-P","article-title":"Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia","volume":"33","author":"Bogerts","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0065","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.4049\/jimmunol.168.7.3667","article-title":"Antibodies against cerebral M1 cholinergic muscarinic receptor from schizophrenic patients: molecular interaction","volume":"168","author":"Borda","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2012.08.005_b0070","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2012.08.005_b0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2012.08.005_b0080","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","article-title":"Neuroinflammation in schizophrenia-related psychosis: a PET study","volume":"50","author":"Doorduin","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbi.2012.08.005_b0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/ern.09.144","article-title":"The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder","volume":"10","author":"Drexhage","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbi.2012.08.005_b0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbi.2006.03.005","article-title":"Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses","volume":"21","author":"Frank","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2012.08.005_b0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.it.2006.11.004","article-title":"What is immune privilege (not)?","volume":"28","author":"Galea","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbi.2012.08.005_b0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0920-9964(94)90004-3","article-title":"Increased prevalence of antibrain antibodies in the sera from schizophrenic patients","volume":"14","author":"Henneberg","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2012.08.005_b0105","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1176\/ajp.155.10.1384","article-title":"Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects","volume":"155","author":"Hirayasu","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0110","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1177\/30.10.6182185","article-title":"Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry","volume":"30","author":"Hsu","year":"1982","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbi.2012.08.005_b0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archpsyc.58.2.165","article-title":"A separate disease within the syndrome of schizophrenia","volume":"58","author":"Kirkpatrick","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4088\/JCP.08m04666yel","article-title":"A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia","volume":"71","author":"Levkovitz","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nm.1927","article-title":"Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke","volume":"15","author":"Liesz","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2012.08.005_b0130","series-title":"Atlas of the Human Brain","author":"Mai","year":"2003"},{"key":"10.1016\/j.bbi.2012.08.005_b0135","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbi.2008.08.003","article-title":"Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders","volume":"23","author":"Maxeiner","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2012.08.005_b0140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0145","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pnpbp.2006.08.013","article-title":"Possible antipsychotic effects of minocycline in patients with schizophrenia","volume":"31","author":"Miyaoka","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1819.2009.01945.x","article-title":"Cytokines and schizophrenia: microglia hypothesis of schizophrenia","volume":"63","author":"Monji","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2012.08.005_b0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0920-9964(94)00045-A","article-title":"Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology","volume":"14","author":"M\u00fcller","year":"1995","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2012.08.005_b0160","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.schres.2010.04.015","article-title":"Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment","volume":"121","author":"M\u00fcller","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2012.08.005_b0165","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1176\/ajp.156.4.634","article-title":"Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood\u2013brain barrier permeability in schizophrenia","volume":"156","author":"M\u00fcller","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0170","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","article-title":"Kynurenines: from the perspective of major psychiatric disorders","volume":"279","author":"Myint","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.bbi.2012.08.005_b0175","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-3223(00)01120-3","article-title":"Three-dimensional mapping of temporo-limbic regions and the lateral ventricles in schizophrenia: gender effects","volume":"50","author":"Narr","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0180","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1176\/ajp.156.11.1725","article-title":"Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes","volume":"156","author":"Nikkil\u00e4","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0185","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0920-9964(99)00218-2","article-title":"Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia","volume":"49","author":"Nikkil\u00e4","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2012.08.005_b0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0920-9964(02)00288-8","article-title":"Anterior hippocampal volume reduction in male patients with schizophrenia","volume":"60","author":"Pegues","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2012.08.005_b0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.schres.2007.04.034","article-title":"Left posterior hippocampal density reduction using VBM and stereological MRI procedures in schizophrenia","volume":"96","author":"Rametti","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2012.08.005_b0200","first-page":"79","article-title":"Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics","volume":"21","author":"Reiber","year":"2003","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.bbi.2012.08.005_b0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/15622975.2010.530690","article-title":"Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study","volume":"12","author":"Schmitt","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00401-008-0430-y","article-title":"Stereologic investigation of the posterior part of the hippocampus in schizophrenia","volume":"117","author":"Schmitt","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2012.08.005_b0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0006-3223(99)00206-1","article-title":"Decreased levels of soluble intercellular adhesion molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients","volume":"47","author":"Schwarz","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0220","doi-asserted-by":"crossref","first-page":"278531","DOI":"10.1155\/2009\/278531","article-title":"Breaching the blood\u2013brain barrier as a gate to psychiatric disorder","volume":"2009","author":"Shalev","year":"2009","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"10.1016\/j.bbi.2012.08.005_b0225","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpsychires.2006.10.013","article-title":"Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide","volume":"42","author":"Steiner","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2012.08.005_b0230","doi-asserted-by":"crossref","unstructured":"Steiner, J., Bogerts, B., Sarnyai, Z., Walter, M., Gos, T., Bernstein, H.G., Myint, A.M., 2011a. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: potential role of glial NMDA receptor modulators and impaired blood\u2013brain barrier integrity. World J Biol. Psychiatry, in press","DOI":"10.3109\/15622975.2011.583941"},{"key":"10.1016\/j.bbi.2012.08.005_b0235","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00406-010-0098-x","article-title":"Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity","volume":"260","author":"Steiner","year":"2010","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2012.08.005_b0240","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-006-0090-8","article-title":"Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization","volume":"112","author":"Steiner","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2012.08.005_b0245","doi-asserted-by":"crossref","unstructured":"Steiner, J., Walter, M., Glanz, W., Sarnyai, Z., Bernstein, H.G., Vielhaber, S., K\u00e4stner, A., Skalej, M., Jordan, W., Schiltz, K., Klingbeil, C., Wandinger, K.P., Bogerts, B., St\u00f6cker, W., 2013. Increased prevalence of diverse NMDA receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from NMDA receptor encephalitis. Jama. Psychiatry, in press.","DOI":"10.1001\/2013.jamapsychiatry.86"},{"issue":"1","key":"10.1016\/j.bbi.2012.08.005_b0320","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-8-94","article-title":"Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?","volume":"8","author":"Steiner","year":"2011","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.bbi.2012.08.005_b0255","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1176\/appi.ajp.160.12.2190","article-title":"Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia","volume":"160","author":"Szeszko","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0260","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0925-4927(91)90011-E","article-title":"Gadolinium-DTPA enhanced gradient echo magnetic resonance scans in first episode of psychosis and chronic schizophrenic patients","volume":"40","author":"Szymanski","year":"1991","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2012.08.005_b0265","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1017\/S1461145710000313","article-title":"Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106","volume":"13","author":"Takano","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2012.08.005_b0270","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(03)00252-2","article-title":"Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders","volume":"141","author":"Tanaka","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2012.08.005_b0275","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1176\/ajp.142.5.657","article-title":"Permeability of the blood\u2013brain barrier in psychiatric patients","volume":"142","author":"Torrey","year":"1985","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0280","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-244X-12-37","article-title":"Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features","volume":"12","author":"Tsutsui","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0285","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/15622970903414188","article-title":"Ultrastructural damage of capillaries in the neocortex in schizophrenia","volume":"11","author":"Uranova","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0290","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study","volume":"64","author":"van Berckel","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0315","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0006-3223(01)01121-0","article-title":"Selective bilateral hippocampal volume loss in chronic schizophrenia","volume":"50","author":"Velakoulis","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2012.08.005_b0300","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/(SICI)1099-1611(199712)6:4<290::AID-PON283>3.0.CO;2-G","article-title":"The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trial","volume":"6","author":"Walker","year":"1997","journal-title":"Psychooncology"},{"key":"10.1016\/j.bbi.2012.08.005_b0305","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pscychresns.2004.05.004","article-title":"Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study","volume":"131","author":"Yamasue","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2012.08.005_b0310","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-8993(94)90006-X","article-title":"Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6","volume":"643","author":"Zalcman","year":"1994","journal-title":"Brain Res."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159112003923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159112003923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:32:06Z","timestamp":1760167926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159112003923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0889159112003923"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2012.08.005","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: Further evidence for disease course-related immune alterations?","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2012.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}